SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-142959
Filing Date
2019-05-09
Accepted
2019-05-09 16:04:02
Documents
4
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d744723d8k.htm 8-K 15802
2 EX-99.1 d744723dex991.htm EX-99.1 39940
3 GRAPHIC g744723g0509084831602.jpg GRAPHIC 2920
4 GRAPHIC g744723g29f83.jpg GRAPHIC 12838
  Complete submission text file 0001193125-19-142959.txt   78319
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33095 | Film No.: 19810433
SIC: 2834 Pharmaceutical Preparations